Absolutely all dossiers for medicinal products registered in the EAEU countries must be brought in accordance with the requirements of the Eurasian Economic Union by December 31, 2025.

The Eurasian Economic Commission (EEC) called on pharmaceutical manufacturers to intensify their efforts in this direction. 

Pharmaceutical manufacturers have a lot of work to complete in order to finish all procedures by December 31, 2025. To achieve these goals, Inpharmatis offers pharmaceutical manufacturers an optimally planned process for bringing the dossier in line with the EAEU rules, and full support.

Inpharmatis is an international consulting group of companies that provides a full range of services for the registration of medicines and bringing the registration dossier in accordance with the requirements of the EAEU. Highly qualified experts of Inpharmatis have many years of experience of successful work in the EAEU countries and provide full support to the client at every stage of registration. For more information, please contact us info@inpharmatis.com